Haleon plc
NYSE: HLN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Brian James McNamara
- Employees
- 24,561
- Headquarters
- Weybridge, United Kingdom
- IPO year
- 2022
- Market cap
- $39.6B
- Website
- https://www.haleon.com
Loading HLN…
Loading profile data…Frequently asked questions about HLN
What does Haleon plc (HLN) do?
Haleon plc is a significant global entity in the consumer healthcare sector, engaging in the entire process from scientific research and development to the production and worldwide distribution of various wellness goods. The company's reach extends across North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific region....
Where does HLN trade?
Haleon plc (HLN) trades on the New York Stock Exchange.
What sector is HLN in?
Haleon plc (HLN) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Haleon plc?
Brian James McNamara is the chief executive officer of Haleon plc (HLN).
Where is Haleon plc headquartered?
Haleon plc is headquartered in United Kingdom.
Does HLN pay a dividend?
Yes — Haleon plc (HLN) paid a trailing twelve-month dividend of USD 0.19 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did HLN go public?
Haleon plc (HLN) completed its initial public offering in 2022.
Is HLN an ADR?
Yes — HLN is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Haleon plc reporting and dividends follow the underlying issuer.